# Compass Therapeutics, Inc.: Form 8-K, filed Jun 23, 2020

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2020-06-23
- Accepted by EDGAR: Jun 23, 2020, 21:15 ET
- Period: 2020-06-17
- Accession: 0001213900-20-015594
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000121390020015594/ea123278-8k_compasstherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000121390020015594/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 4.01: Change of auditor
- Item 5.01: Change in control
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.06: Item not in the standard list
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000121390020015594/ea123278-8k_compasstherap.htm

Filed Jun 23, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-015594. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.